Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Internal Medicine Physician in La Jolla, CA
NPI: 1376718890Primary Practice Location
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
9888 Genesee Ave, La Jolla, CA
Primary Employer
La Jolla Pulmonary and Critical Care Inc.
scripps.org
HQ Phone
Get M.D. Daniel's Phone Numberphone_androidMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2025
NY State Medical License
2012 - 2019
American Board of Internal Medicine
Critical Care Medicine
American Board of Internal Medicine
Pulmonary Disease
New York Presbyterian Hospital (Cornell Campus)
Fellowship • Pulmonary Disease and Critical Care Medicine
2014 - 2017
University of California (San Diego) Medical Center
Residency • Internal Medicine
2006 - 2009
Sidney Kimmel Medical College
jefferson.edu
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 89 | 222 |
| 2 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 49 | 72 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 39 | 84 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 25 | 41 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 12 | 13 |
TCR Antagonism by Peptide Requires High TCR Expression
Authors: Peter Reichardt, Mandy L. Ford, Lindsay J. Edwards, Brian D. Evavold, Jones, D. S., Daniel S. Jones
Publication Date: 2008-08
Defining the parameters necessary for T-cell recognition of ligands that vary in potency.
Authors: Neely E. Kilgore, Mandy L. Ford, Carrie D. Margot, Peter Reichardt, Brian D. Evavold, Jones, D. S., Daniel S. Jones
Publication Date: 2004-01
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: Placebo, DRUG: Inhaled Treprostinil, DEVICE: Treprostinil Ultrasonic Nebulizer
Lead Sponsor: NYU Langone Health
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: DRUG: Anticoagulant Therapy, DEVICE: Catheter-Directed Therapy
Lead Sponsor: United Therapeutics
Intervention / Treatment: DRUG: Placebo, DRUG: Inhaled Treprostinil, DEVICE: Treprostinil Ultrasonic Nebulizer
